Billionaires Holding FLXN

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 15.6M
    Shares Outstanding

  • 525.49M
    Market Cap

News & Insights

ABOUT

FLXN

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes FX006, a sustained-release intra-articula...

Procter & Gamble Co.'s Worst Moves in 2016

NEWS

US STOCKS-Wall St set to open flat as investors test rally

READ MORE